| Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr4) ST Qureshi, L Larivière, G Leveque, S Clermont, KJ Moore, P Gros, ... Journal of Experimental Medicine 189 (4), 615-625, 1999 | 2065 | 1999 |
| Type I interferon restricts type 2 immunopathology through the regulation of group 2 innate lymphoid cells CU Duerr, CDA McCarthy, BC Mindt, M Rubio, AP Meli, J Pothlichet, ... Nature immunology 17 (1), 65-75, 2016 | 369 | 2016 |
| Toll-like receptors and their role in experimental models of microbial infection ST Qureshi, R Medzhitov Genes & Immunity 4 (2), 87-94, 2003 | 209 | 2003 |
| Cutting edge: TLR4 deficiency confers susceptibility to lethal oxidant lung injury X Zhang, P Shan, S Qureshi, R Homer, R Medzhitov, PW Noble, PJ Lee The Journal of Immunology 175 (8), 4834-4838, 2005 | 185 | 2005 |
| The role of toll-like receptors in acute and chronic lung inflammation EI Lafferty, ST Qureshi, M Schnare Journal of Inflammation 7, 1-14, 2010 | 163 | 2010 |
| Cutting edge: functional characterization of the effect of the C3H/HeJ defect in mice that lack an Lpsn gene: in vivo evidence for a dominant negative mutation SN Vogel, D Johnson, PY Perera, A Medvedev, L Larivière, ST Qureshi, ... The Journal of Immunology 162 (10), 5666-5670, 1999 | 162 | 1999 |
| Systems analysis of a RIG-I agonist inducing broad spectrum inhibition of virus infectivity ML Goulet, D Olagnier, Z Xu, S Paz, SM Belgnaoui, EI Lafferty, V Janelle, ... PLoS pathogens 9 (4), e1003298, 2013 | 148 | 2013 |
| Effect of probiotics on incident ventilator-associated pneumonia in critically ill patients: a randomized clinical trial J Johnstone, M Meade, F Lauzier, J Marshall, E Duan, J Dionne, YM Arabi, ... Jama 326 (11), 1024-1033, 2021 | 136 | 2021 |
| Host resistance to infection: genetic control of lipopolysaccharide responsiveness by TOLL-like receptor genes ST Qureshi, P Gros, D Malo Trends in Genetics 15 (8), 291-294, 1999 | 133 | 1999 |
| Toll-like receptors differentially regulate CC and CXC chemokines in skeletal muscle via NF-κB and calcineurin JH Boyd, M Divangahi, L Yahiaoui, D Gvozdic, S Qureshi, BJ Petrof Infection and immunity 74 (12), 6829-6838, 2006 | 123 | 2006 |
| Cryptococcus gattii: An Emerging Cause of Fungal Disease in North America A Dixit, SF Carroll, ST Qureshi Interdisciplinary perspectives on infectious diseases 2009 (1), 840452, 2009 | 118 | 2009 |
| Toll-like receptors: sentinels of host defence against bacterial infection M Schnare, M Röllinghoff, S Qureshi International archives of allergy and immunology 139 (1), 75-85, 2005 | 112 | 2005 |
| Inhibition of mammalian target of rapamycin augments lipopolysaccharide-induced lung injury and apoptosis JA Fielhaber, SF Carroll, AB Dydensborg, M Shourian, ... The Journal of Immunology 188 (9), 4535-4542, 2012 | 108 | 2012 |
| Toll-like receptor 4 ablation in mdx mice reveals innate immunity as a therapeutic target in Duchenne muscular dystrophy C Giordano, K Mojumdar, F Liang, C Lemaire, T Li, J Richardson, ... Human molecular genetics 24 (8), 2147-2162, 2015 | 96 | 2015 |
| Immune recognition of fungal polysaccharides BD Snarr, ST Qureshi, DC Sheppard Journal of fungi 3 (3), 47, 2017 | 94 | 2017 |
| Regulation of angiopoietin expression by bacterial lipopolysaccharide M Mofarrahi, T Nouh, S Qureshi, L Guillot, D Mayaki, SNA Hussain American Journal of Physiology-Lung Cellular and Molecular Physiology 294 (5 …, 2008 | 92 | 2008 |
| IL-33 signaling regulates innate and adaptive immunity to Cryptococcus neoformans A Flaczyk, CU Duerr, M Shourian, EI Lafferty, JH Fritz, ST Qureshi The Journal of Immunology 191 (5), 2503-2513, 2013 | 84 | 2013 |
| NLRP7, a nucleotide oligomerization domain-like receptor protein, is required for normal cytokine secretion and co-localizes with Golgi and the microtubule-organizing center C Messaed, E Akoury, U Djuric, J Zeng, M Saleh, L Gilbert, M Seoud, ... Journal of Biological Chemistry 286 (50), 43313-43323, 2011 | 83 | 2011 |
| Enhanced Innate Immune Responsiveness to Pulmonary Cryptococcus neoformans Infection Is Associated with Resistance to Progressive Infection L Guillot, SF Carroll, R Homer, ST Qureshi Infection and immunity 76 (10), 4745-4756, 2008 | 83 | 2008 |
| Innate immune B cell activation by Leishmania donovani exacerbates disease and mediates hypergammaglobulinemia S Silva-Barrios, M Smans, CU Duerr, ST Qureshi, JH Fritz, A Descoteaux, ... Cell Reports 15 (11), 2427-2437, 2016 | 80 | 2016 |
